Intimation of participation in the Investor Conferences
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the stock exchanges that its officials will participate in two investor conferences in Mumbai: the Nirmal Bang Conference on May 27, 2025 and the B&K Trinity India 2025 conference on May 28, 2025. The disclosure is made under SEBI's Listing Regulations as a standard compliance update. The company clarified that no unpublished price-sensitive information will be shared at these events. The schedule remains subject to change depending on circumstances.
This is a routine regulatory disclosure with no direct impact on the company's financials or stock price. It signals continued engagement with the investor community, which is neutral to mildly positive for visibility but unlikely to move the stock.